Radiation Proctitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiation Proctitis market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Proctitis Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Prevalence of Urinary Incontinence, by Region
5.2. Key Industry Events
5.3. Regulatory Scenario
5.4. Technological Advancements
5.5. Key Success Factors of Top Players

6. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication
6.1. Introduction & Definition
6.2. Global Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
6.2.1. Acute Radiation Proctitis
6.2.2. Chronic Radiation Proctitis
6.3. Global Radiation Proctitis Market Attractiveness Analysis, by Indication

7. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy
7.1. Introduction & Definition
7.2. Global Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
7.2.1. Oral Therapy
7.2.1.1. Antidiarrheals
7.2.1.2. Anti-inflammatory Agents
7.2.1.3. Others
7.2.2. Ablative Procedures
7.2.3. Hyperbaric Oxygen Therapy
7.2.4. Formalin
7.2.5. Surgery

8. Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region
8.1. Introduction
8.2. Radiation Proctitis Market Value Forecast, by Region, 2018–2030
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Radiation Proctitis Market Attractiveness Analysis, by Region

9. North America Radiation Proctitis Market Analysis and Forecast
9.1. Introduction
9.2. North America Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
9.2.1. Acute Radiation Proctitis
9.2.2. Chronic Radiation Proctitis
9.3. North America Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
9.3.1. Oral Therapy
9.3.1.1. Antidiarrheals
9.3.1.2. Anti-inflammatory Agents
9.3.1.3. Others
9.3.2. Ablative Procedures
9.3.3. Hyperbaric Oxygen Therapy
9.3.4. Formalin
9.3.5. Surgery
9.4. North America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Radiation Proctitis Market Attractiveness Analysis
9.5.1. By Indication
9.5.2. By Therapy
9.5.3. By Country/Sub-region

10. Europe Radiation Proctitis Market Analysis and Forecast
10.1. Introduction
10.2. Europe Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
10.2.1. Acute Radiation Proctitis
10.2.2. Chronic Radiation Proctitis
10.3. Europe Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
10.3.1. Oral Therapy
10.3.1.1. Antidiarrheals
10.3.1.2. Anti-inflammatory Agents
10.3.1.3. Others
10.3.2. Ablative Procedures
10.3.3. Hyperbaric Oxygen Therapy
10.3.4. Formalin
10.3.5. Surgery
10.4. Europe Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Radiation Proctitis Market Attractiveness Analysis
10.5.1. By Indication
10.5.2. By Therapy
10.5.3. By Country/Sub-region

11. Asia Pacific Radiation Proctitis Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
11.2.1. Acute Radiation Proctitis
11.2.2. Chronic Radiation Proctitis
11.3. Asia Pacific Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
11.3.1. Oral Therapy
11.3.1.1. Antidiarrheals
11.3.1.2. Anti-inflammatory Agents
11.3.1.3. Others
11.3.2. Ablative Procedures
11.3.3. Hyperbaric Oxygen Therapy
11.3.4. Formalin
11.3.5. Surgery
11.4. Asia Pacific Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Radiation Proctitis Market Attractiveness Analysis
11.5.1. By Indication
11.5.2. By Therapy
11.5.3. By Country/Sub-region

12. Latin America Radiation Proctitis Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
12.2.1. Acute Radiation Proctitis
12.2.2. Chronic Radiation Proctitis
12.3. Latin America Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
12.3.1. Oral Therapy
12.3.2. Ablative Procedures
12.3.3. Hyperbaric Oxygen Therapy
12.3.4. Formalin
12.3.5. Surgery
12.4. Latin America Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Radiation Proctitis Market Attractiveness Analysis
12.5.1. By Indication
12.5.2. By Therapy
12.5.3. By Country/Sub-region

13. Middle East & Africa Radiation Proctitis Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Radiation Proctitis Market Value Forecast, by Indication, 2018–2030
13.2.1. Acute Radiation Proctitis
13.2.2. Chronic Radiation Proctitis
13.3. Middle East & Africa Radiation Proctitis Market Value Forecast, by Therapy, 2018–2030
13.3.1. Oral Therapy
13.3.1.1. Antidiarrheals
13.3.1.2. Anti-inflammatory Agents
13.3.1.3. Others
13.3.2. Ablative Procedures
13.3.3. Hyperbaric Oxygen Therapy
13.3.4. Formalin
13.3.5. Surgery
13.4. Middle East & Africa Radiation Proctitis Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Radiation Proctitis Market Attractiveness Analysis
13.5.1. By Indication
13.5.2. By Therapy
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Global Radiation Proctitis Market Share Analysis, by Company, 2019
14.2. Company Profiles
14.2.1. Allergan plc
14.2.1.1. Company Description
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Teva Pharmaceutical Industries Ltd.
14.2.2.1. Company Description
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Amneal Pharmaceuticals, Inc.
14.2.3.1. Company Description
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Pfizer, Inc.
14.2.4.1. Company Description
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Mylan, Inc., (Viatris)
14.2.5.1. Company Description
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Sanofi
14.2.6.1. Company Description
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Johnson & Johnson (Johnson & Johnson Consumer, Inc.)
14.2.7.1. Company Description
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Sun Pharmaceutical Industries Ltd.
14.2.8.1. Company Description
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Environmental Tectonics Corporation
14.2.9.1. Company Description
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Sechrist Industries, Inc.
14.2.10.1. Company Description
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis

List of Figures

Figure 01: Global Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Radiation Proctitis Market Value Share, by Indication, 2019

Figure 03: Global Radiation Proctitis Market Value Share, by Therapy, 2019

Figure 04: Global Radiation Proctitis Market Value Share, by Region, 2019

Figure 05: Global Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 06: Global Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 07: Global Radiation Proctitis Market Value (US$ Mn), by Acute Radiation Proctitis, 2018–2030

Figure 08: Global Radiation Proctitis Market Value (US$ Mn), by Chronic Radiation Proctitis, 2018–2030

Figure 09: Global Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 10: Global Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

Figure 11: Global Radiation Proctitis Market Value (US$ Mn), by Oral Therapy, 2018–2030

Figure 12: Global Radiation Proctitis Market Value (US$ Mn), by Ablative Procedures, 2018–2030

Figure 13: Global Radiation Proctitis Market Value (US$ Mn), by Hyperbaric Oxygen Therapy, 2018–2030

Figure 14: Global Radiation Proctitis Market Value (US$ Mn), by Formalin, 2018–2030

Figure 15: Global Radiation Proctitis Market Value (US$ Mn), by Surgery, 2018–2030

Figure 16: Global Radiation Proctitis Market Value Share Analysis, by Region, 2019 and 2030

Figure 17: Global Radiation Proctitis Market Attractiveness Analysis, by Region, 2020–2030

Figure 18: North America Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 19: North America Radiation Proctitis Market Value Share Analysis, by Country, 2019 and 2030

Figure 20: North America Radiation Proctitis Market Attractiveness Analysis, by Country, 2020–2030

Figure 21: North America Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 22: North America Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 23: North America Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 24: North America Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

Figure 25: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 26: Europe Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 27: Europe Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 28: Europe Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 29: Europe Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 30: Europe Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 31: Europe Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

Figure 32: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 33: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 34: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 35: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 36: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 37: Asia Pacific Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 38: Asia Pacific Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

Figure 39: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 40: Latin America Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 41: Latin America Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 42: Latin America Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 43: Latin America Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 44: Latin America Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 45: Latin America Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

Figure 46: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 47: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 48: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 49: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Indication, 2019 and 2030

Figure 50: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Indication, 2020–2030

Figure 51: Middle East & Africa Radiation Proctitis Market Value Share Analysis, by Therapy, 2019 and 2030

Figure 52: Middle East & Africa Radiation Proctitis Market Attractiveness Analysis, by Therapy, 2020–2030

List of Tables

Table 01: Radiation Proctitis: Clinical Trial Pipeline Analysis (1/2)

Table 02: Radiation Proctitis: Clinical Trial Pipeline Analysis (2/2)

Table 03: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (1/2)

Table 04: Estimated Number of Patients with Radiation Proctitis, by Key indications, by Key Countries 2020 (2/2)

Table 05: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 06: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 07: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030

Table 08: Global Radiation Proctitis Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 11: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 12: North America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030

Table 13: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 15: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 16: Europe Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030

Table 17: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 19: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 20: Asia Pacific Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030

Table 21: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 22: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 23: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 24: Latin America Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030

Table 25: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Indication, 2018–2030

Table 27: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Therapy, 2018–2030

Table 28: Middle East & Africa Radiation Proctitis Market Value (US$ Mn) Forecast, by Oral Therapy, 2018–2030